key: cord-0745562-rscduazd authors: Ji, Weiping; Zhang, Jing; Bishnu, Gautam; Du, Xudong; Chen, Xinxin; Xu, Hui; Guo, Xiaoling; Cai, Zhenzhai; Shen, Xian title: Comparison of severe and non-severe COVID-19 pneumonia: review and meta-analysis date: 2020-03-09 journal: nan DOI: 10.1101/2020.03.04.20030965 sha: e066fdbb4a9338a57477424cb66fd4d75b2fd66d doc_id: 745562 cord_uid: rscduazd Objective: To compare the difference between severe and non-severe COVID-19 pneumonia and figure out the potential symptoms lead to severity. Methods: Articles from PubMed, Embase, Cochrane database, and google up-to 24 February 2020 were systematically reviewed. Eighteen Literatures were identified with cases of COVID-19 pneumonia. The extracted data includes clinical symptoms, age, gender, sample size and region et al were systematic reviewed and meta analyzed. Results: 14 eligible studies including 1,424 patients were analyzed. Symptoms like fever (89.2%), cough (67.2%), fatigue (43.6%) were common, dizziness, hemoptysis, abdominal pain and conjunctival congestion/conjunctivitis were rare. Polypnea/dyspnea in severe patients were significantly higher than non-severe (42.7% vs.16.3%, P<0.0001). Fever and diarrhea were higher in severe patients(p=0.0374and0.0267). Further meta-analysis showed incidence of fever(OR1.70,95%CI 1.01-2.87), polypnea/dyspnea(OR3.53, 95%CI 1.95-6.38) and diarrhea(OR1.80,95%CI 1.06-3.03) was higher in severe patients, which meant the severe risk of patients with fever, polypnea/dyspnea, diarrhea were 1.70, 3.53, 1.80 times higher than those with no corresponding symptoms. Conclusions: Fever, cough and fatigue are common symptoms in COVID-19 pneumonia. Compared with non-severe patients, the symptoms as fever, polypnea/dyspnea and diarrhea are potential symptoms lead to severity. We conducted a comprehensive systematic search of PubMed, Embase, Cochrane database, and google to find all published studies that describe the clinical characteristics of COVID-19, using the search terms, "novel coronavirus", "SARS-CoV-2", "COVID-19". According to title and abstract, two independent researchers selected and classified literatures, and reviewed all followed criteria. Literatures described NCP patient's clinical signs. If there were duplicates in the study population, the literature with the largest sample size will be included. Cases that did not describe the clinical characteristics of NCP patients and repeated cases were Classification variables were summarized as counts and percentages in each category. The age, gender, number and clinical signs of NCP patients were statistically described; Cochran-mantel-Haenszel test (stratified chi-square test) was used to compare the differences between severe and non-severe NCP. With OR (Odds ratio) as the effect quantity, we used Mantel-Haenszel test with fixed or random effect for further meta-analysis of the clinical signs with statistical differences, and showed by drawing forest map. Symmetry tested by funnel plot. A total of 333 relevant literatures published in PubMed and other databases were detected, 68 were removed because of duplication. 265 were removed based on the inclusion criteria. 23 literaturesdid not report clinical signs. 4 were excluded because of casesoverlapped[8-9.12-13]. Finally, 14 articles were included for the final . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03.04.20030965 doi: medRxiv preprint analysis[10-11.14-25]. Fig 1 shows the study selection flowchart. Data from all eligible studies were obtained frompublished manuscripts. A systematic review showed that 610 patients (42.8%) with NCP were female. Fever (89.2%) and cough (67.2%) were the most common symptoms, followed by fatigue (43.6%), phlegm (28.6%), shortness of breath/difficulty(21.7%), and the less common symptoms were dizziness, hemoptysis, abdominalpain, conjunctivalcongestion/conjunctivitis.1,377 cases were divided into severe group (1, 110) and non-severe group (267), Stratified chi-square test showed that there was nosignificant difference in gender between the two groups(P>0.05), and the median age in the non-severe group (967 fever,88.31%) were used to meta analysis for fever; Three studies were considered to be homogeneous, and fixed effect model(Chi 2 =0.88, P=0.64, I 2 =0%). The pooled effect was 1.70 (95%CI, 1.01-2.87) indicating fever patients had a 1.70 times higher incidence of severe risk than non-fever. On symptoms of polypnea/dyspnea, 262 cases in the severe group(112 polypnea/dyspnea,42.75%) and 1095 cases in the non-severe group(179polypnea/dyspnea,68.32%). Test showed that 3 literatures have certain heterogeneity(Chi2=5.26,P=0.07, I2=62%), so the random effect model was adopted; The individual OR effect showed differently, but combined OR effect was 3.53 (95%CI, 1.95-6.38), indicating the incidence of severe risk of the patients with polypnea/dyspnea was 3.53 times higher than those none. On symptoms of diarrhea, 266 cases in the severe group (25 diarrhea,9.40%) and 1,110 cases in the non-severe group (48diarrhea,4.32%). Test showed homogeneity (Chi 2 =0.32, P=0.85,I 2 = 0%) and fixed effect model was used, The combined OR value was 1.80 (95%CI, 1.06-3.03), indicating the incidence of diarrhea in the severe group . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03.04.20030965 doi: medRxiv preprint significantly higher than non-severe group, and the severerisk of diarrheapatients was 1.80 times higher than those none. (See Fig 4) The graphs in funnel plots of fever, polypnea/dyspnea and diarrhea are basically symmetrical, which looks like no significant publication deviation. (See fig 5) There was no difference in proportion of gender between severe and non-severe NCP patients, which was consistent with the latest report [11] [12] [13] [14] . Most of the patients showed fever and cough. Compared with non-severe patients, Fever, Polypnea/dyspnea and Diarrhea were more common in severe patients. But recent reports showed that there was no difference in the proportion of fever and diarrhea between severe and non-severe Our systematic review had limitations. Firstly, most of the data in this study are from retrospective studies and case reports, which usually report successful management and are affected by selection and publication bias. Secondly, the datacollection of some cases is incomplete. So the statistical test and the discovery of p-value should be carefully explained. Thirdly, the number of included studies is not enough, the test . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03.04.20030965 doi: medRxiv preprint efficiency is insufficient, symmetry can be observed, but it is difficult to evaluate symmetry. The common symptoms NCP patients were fever, cough and fatigue. Compared with non-severe NCP patients, the symptoms as fever, polypnea/dyspnea and diarrhea were more common in severe patients. Those were potential symptoms which might lead patients to severity. Weiping Ji, Jing Zhang, Hui Xu, Xiaoling Guo designed and completed the manuscript. Gautam Bishnu and Xudong Du completed data and language work, Zhenzhai Cai and Xinxin Chen completed statistics and verification, Xian Shen completed the review and revision of the paper, and guided the whole process. . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . Figure 1 legend: After selection, 5 papers of group research and 9 articles of case report were eligible, with a total of 1,424 cases. 3 papers with a total of 1,377 cases reported clinical signs of severe and non-severe patients subgroups (literature 2 was divided into ICU and non-ICU, which were assumed equivalent to severe and non-severe). Figure 2 legend: Fever, cough, polypnea/dyspnea and diarrhea were the most common clinical signs reported in the literature, while some other signs were more or less unreported. It assumed that if a certain clinical sign was not reported in a certain literature, it would be treated as none. The comparison of clinical signs between severe and non-severe patients was shown among 1,377 cases, including 1,110 cases of non-severe patients and 267 cases of severe patients. Polypnea/dyspnea, fever and diarrhea showed significantly difference in two groups. In severe patients, conjunctival congestion/conjunctivitis, hemoptysis, anorexia, dizzinessand abdominal pain were more likely to occur, but because some data was incomplete, the results needed to be caution. Further meta-analysis was performed for fever, polypnea/dyspnea, and diarrhea. Effect value OR analysis indicated severe risk of febrile, polypnea/dyspnea and diarrhea patients were 1.70 (95%CI, 1.01-2.87) , 3.53 (95%CI, 1.95-6.38), 1.80 (95%CI, 1.06-3.03) times higher than those none. The graphs in funnel plots of fever, polypnea/dyspnea and diarrhea are basically symmetrical, which preliminary indicates no significant publication deviation. . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03.04.20030965 doi: medRxiv preprint Novel coronavirus -China Genomic characterization and epidemiology of 2019 novel coronavirus: implications of virus origins and receptor binding A novel coronavirus from patients with Pneumonia in China Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle Potential for global spread of a novel coronavirus from China Early transmission dynamics in wuhan, china, of novel coronavirus-infected pneumonia A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia First Case of 2019 Novel Coronavirus in the United States A Locally Transmitted Case of SARS-CoV-2 Infection in Taiwan Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam The authors declared no competing interests exist.